APA

Lotze M. T., Roberts K., Custer M. C., Segal D. A. & Rosenberg S. A. (19870713). Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: a possible approach to the immunotherapy of human tumors. : The Journal of surgical research.

Chicago

Lotze M T, Roberts K, Custer M C, Segal D A and Rosenberg S A. 19870713. Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: a possible approach to the immunotherapy of human tumors. : The Journal of surgical research.

Harvard

Lotze M. T., Roberts K., Custer M. C., Segal D. A. and Rosenberg S. A. (19870713). Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: a possible approach to the immunotherapy of human tumors. : The Journal of surgical research.

MLA

Lotze M T, Roberts K, Custer M C, Segal D A and Rosenberg S A. Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: a possible approach to the immunotherapy of human tumors. : The Journal of surgical research. 19870713.